NCT02065674

Brief Summary

Objective: To ascertain whether homoeopathic medicine ABROMA AUGUSTA has a clinical role in changing the Glycated Hb Level in Diabetes mellitus Type II. Abstract: Background: Type 2 diabetes mellitus (T2DM) is one of the most important epidemic diseases in the world in this century, and accounts for 90% of cases of diabetes globally. Studies have suggested that Abroma Augusta plays a role in acute controlling blood glucose level. The aim of this study was to evaluate the efficacy of "Abroma Augusta Ѳ" in chronic control through GlycatedHb (HbA1c %) in Diabetes Mellitus Type 2 (NIDDM) as a pretest post-test study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2014

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2014

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

February 13, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 19, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

June 9, 2015

Status Verified

June 1, 2015

Enrollment Period

10 months

First QC Date

February 13, 2014

Last Update Submit

June 5, 2015

Conditions

Type II Diabetes Mellitus

Keywords

type II Diabetes mellitusFBSPPBSHbA1c%

Interventions

Abroma Augusta Q (mother tincture)DRUG

30 drops in 1 cup of water three times a day for 3 months

Also known as: Abroma Augustum,

Eligibility Criteria

Age30 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Patient with major complications like diabetic retinopathy and cardiomyopathy. IDDM HbA1c above 11%

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

,Father Muller Homoeopathic Medical College, Prasanth Nivas Ashram Nmpt Hospital

Mangalore, Karnataka, 575002, India

AVAILABLE

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • dr rita chakraborty, MD

    Fr Muller Homoeopathic Medical College

    PRINCIPAL INVESTIGATOR

Central Study Contacts

dr rita chakraborty, MD

CONTACT

+919448309048ritapranab@gmail.com

Study Design

Study Type
expanded access
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PROFESSOR, Head of The Department of Repertory

Study Record Dates

First Submitted

February 13, 2014

First Posted

February 19, 2014

Study Start

February 1, 2014

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

June 9, 2015

Record last verified: 2015-06

Locations

IN(1)